Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Viking Therapeutics stock jumps 11% as CEO flags broader appetite for obesity-drug deals

Viking Therapeutics stock jumps 11% as CEO flags broader appetite for obesity-drug deals

Shares of Viking Therapeutics climbed roughly 11% on Wednesday, rising from a $30.44–$34.08 range to $34.06 by 1:09 p.m. EST. The move came amid renewed deal speculation in obesity treatments. CEO Brian Lian noted that interest was “broader than is visible” with more players “circling around the space.” Analysts put the potential market at $150 billion annually, and Pfizer’s $10 billion acquisition of Metsera last November has kept deal activity intense.
14 January 2026
StubHub stock (STUB) hit by IPO disclosure lawsuit as Jan. 23 deadline nears

StubHub stock (STUB) hit by IPO disclosure lawsuit as Jan. 23 deadline nears

StubHub Holdings shares dropped roughly 1.8% Wednesday after shareholder law firms pushed investors to step forward for lead-plaintiff status by Jan. 23. The move relates to a securities class action linked to the ticket marketplace’s September IPO. https://www.prnewswire.com/news-releases/stubhub-stub-facing-with-securities-lawsuit-over-ipo-disclosures----hagens-berman-302661277.html
14 January 2026
1 253 254 255 256 257 609
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.